Skip to main content
Equibles

Martin H. Huber, MD

Board Member

Actuate Therapeutics, Inc. (ACTU)

Equibles does not estimate personal net worth.

Get an email with a short summary when Actuate Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ACTU alerts

About Martin H. Huber, MD

Martin H. Huber, MD is recorded as Board Member at Actuate Therapeutics, Inc. (ACTU) since May 1, 2026. Actuate Therapeutics, Inc. reported in an 8-K filed May 6, 2026 that Martin H. Huber, MD was appointed Class III director, effective May 1, 2026. Actuate Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Actuate Therapeutics, Inc. includes Daniel M. Schmitt (CEO and Board Member), Paul Lytle (CFO), Andrew P. Mazar (COO) and 7 others.

“On May 1, 2026, the Board of Directors ("Board") of Actuate Therapeutics, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Martin H. Huber, MD, to the Board.”
Actuate Therapeutics, Inc. Form 8-K, filed May 6, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Actuate Therapeutics, Inc.

Recent activity